Corporate calendar for Connect Biopharma Holdings Limited (CNTB): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | $0.05 | $157M |
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | $0.10 | $672M |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 |
Price
| Price | $1.24 |
| Market Cap | $78M |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 5 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 5 |
| Avg rating (1-5) | 1.00 |
Related companies: ARTV · CNTX · IFRX · IMA · KLRS · MGX · OVID
Explore sector: Healthcare · Biotechnology
More sections of CNTB: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks